| 臺大學術典藏 |
2021-05-31T07:03:14Z |
Snake Venom Disintegrin Inhibits the Activation of Toll-Like Receptors and Alleviates Sepsis through Integrin alphaVbeta3 Blockade
|
Hsu C.-C.; Chuang W.-J.; Chung C.-H.; Chang C.-H.; Peng H.-C.; TUR-FU HUANG |
| 臺大學術典藏 |
2021-05-31T07:03:13Z |
Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1
|
Chung C.H.; Chang C.H.; Hsu C.C.; Lin K.T.; Peng H.C.; TUR-FU HUANG |
| 臺大學術典藏 |
2021-05-31T07:03:13Z |
The disintegrin, trimucrin, suppresses LPS-induced activation of phagocytes primarily through blockade of NF-κB and MAPK activation
|
Hung Y.-C.; Hsu C.-C.; Chung C.-H.; TUR-FU HUANG |
| 臺大學術典藏 |
2021-05-31T07:03:12Z |
Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet
|
Chang C.-H.; Chung C.-H.; Tu Y.-S.; Tsai C.-C.; Hsu C.-C.; Peng H.-C.; Tseng Y.J.; TUR-FU HUANG |
| 臺大學術典藏 |
2021-05-31T07:03:11Z |
From discovery of snake venom disintegrins to a safer therapeutic antithrombotic agent
|
Kuo Y.-J.;Chung C.-H.;Tur-Fu Huang; Kuo Y.-J.; Chung C.-H.; TUR-FU HUANG |
| 臺大學術典藏 |
2021-05-31T07:03:10Z |
Improved antithrombotic activity and diminished bleeding side effect of a PEGylated alphaIIb beta 3 antagonist, disintegrin
|
Kuo Y.-J.; Chang Y.T.; Chung C.-H.; Chuang W.-J.; TUR-FU HUANG |
| 臺大學術典藏 |
2021-05-31T07:03:10Z |
A novel alpha iIb beta 3 antagonist from snake venom prevents thrombosis without causing bleeding
|
Kuo Y.-J.;Chung C.-H.;Pan T.-Y.;Chuang W.-J.;Tur-Fu Huang; Kuo Y.-J.; Chung C.-H.; Pan T.-Y.; Chuang W.-J.; TUR-FU HUANG |
| 臺大學術典藏 |
2021-05-31T06:18:12Z |
The vascular and cardioprotective effects of liriodenine in ischemia-reperfusion injury via NO-dependent pathway
|
Chang W.-L.; Chung C.-H.; Wu Y.-C.; MING-JAI SU |
| 臺大學術典藏 |
2021-05-31T06:17:53Z |
Electronegative LDL-mediated cardiac electrical remodeling in a rat model of chronic kidney disease
|
Lee A.-S.;Chen W.-Y.;Chan H.-C.;Chung C.-H.;Peng H.-Y.;Chang C.-M.;Ming-Jai Su;Chen C.-H.;Chang K.-C.; Lee A.-S.; Chen W.-Y.; Chan H.-C.; Chung C.-H.; Peng H.-Y.; Chang C.-M.; MING-JAI SU; Chen C.-H.; Chang K.-C. |
| 臺大學術典藏 |
2021-03-04T07:50:46Z |
Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules
|
Ho, S.-Y.;Chen, P.-R.;Chen, C.-H.;Tsai, N.-M.;Lin, Y.-H.;Lin, C.-S.;Chuang, C.-H.;Huang, X.-F.;Chan, Y.-L.;Liu, Y.-K.;Chung, C.-H.;Weng, S.-L.;Liao, K.-W.; Ho, S.-Y.; Chen, P.-R.; Chen, C.-H.; Tsai, N.-M.; Lin, Y.-H.; Lin, C.-S.; Chuang, C.-H.; Huang, X.-F.; Chan, Y.-L.; Liu, Y.-K.; Chung, C.-H.; Weng, S.-L.; Liao, K.-W.; CHEN-SI LIN |
